Published in Infect Immun on June 01, 1999
Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad Sci U S A (2004) 4.84
Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J Exp Med (2007) 4.47
IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest (2000) 3.19
Innate immunity to Mycobacterium tuberculosis. Clin Microbiol Rev (2002) 2.79
IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against high-dose challenge. J Immunol (2009) 2.74
Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung. Eur J Immunol (2010) 1.84
Down-modulation of lung immune responses by interleukin-10 and transforming growth factor beta (TGF-beta) and analysis of TGF-beta receptors I and II in active tuberculosis. Infect Immun (2004) 1.60
Regulatory role of T cells producing both interferon gamma and interleukin 10 in persistent infection. J Exp Med (2001) 1.57
Autocrine IL-10 induces hallmarks of alternative activation in macrophages and suppresses antituberculosis effector mechanisms without compromising T cell immunity. J Immunol (2009) 1.47
Tumor necrosis factor alpha-mediated toxic shock in Trypanosoma cruzi-infected interleukin 10-deficient mice. Infect Immun (2000) 1.42
Neonatal mycobacterial specific cytotoxic T-lymphocyte and cytokine profiles in response to distinct BCG vaccination strategies. Immunology (2002) 1.39
Both Th1 and Th2 cytokines affect the ability of monoclonal antibodies to protect mice against Cryptococcus neoformans. Infect Immun (2001) 1.32
Model for immune responses to Mycobacterium avium subspecies paratuberculosis in cattle. Infect Immun (2004) 1.30
Role of TNF-Alpha, IFN-Gamma, and IL-10 in the Development of Pulmonary Tuberculosis. Pulm Med (2012) 1.24
Increased interleukin-10 expression is not responsible for failure of T helper 1 immunity to resolve airborne Mycobacterium tuberculosis infection in mice. Immunology (2003) 1.24
Src homology 3-interacting domain of Rv1917c of Mycobacterium tuberculosis induces selective maturation of human dendritic cells by regulating PI3K-MAPK-NF-kappaB signaling and drives Th2 immune responses. J Biol Chem (2010) 1.20
Increased resistance to mycobacterial infection in the absence of interleukin-10. Immunology (2000) 1.18
Immune regulatory effect of pHSP65 DNA therapy in pulmonary tuberculosis: activation of CD8+ cells, interferon-gamma recovery and reduction of lung injury. Immunology (2004) 1.09
CCL2 responses to Mycobacterium tuberculosis are associated with disease severity in tuberculosis. PLoS One (2009) 1.07
Decreased cytokine production in patients with nontuberculous mycobacterial lung disease. Lung (2007) 1.07
The Mycobacterium tuberculosis complex-restricted gene cfp32 encodes an expressed protein that is detectable in tuberculosis patients and is positively correlated with pulmonary interleukin-10. Infect Immun (2003) 1.07
Infection with the helminth Nippostrongylus brasiliensis does not interfere with efficient elimination of Mycobacterium bovis BCG from the lungs of mice. Clin Diagn Lab Immunol (2002) 1.03
Increased Mycobacterium tuberculosis growth in HIV-1-infected human macrophages: role of tumour necrosis factor-alpha. Clin Exp Immunol (2001) 1.01
Effects of gamma interferon, interleukin-10, and transforming growth factor beta on the survival of Mycobacterium avium subsp. paratuberculosis in monocyte-derived macrophages from naturally infected cattle. Infect Immun (2004) 0.97
ESAT6-induced IFNgamma and CXCL9 can differentiate severity of tuberculosis. PLoS One (2009) 0.97
Protection against tuberculosis by a single intranasal administration of DNA-hsp65 vaccine complexed with cationic liposomes. BMC Immunol (2008) 0.94
Role of phosphatidylinositol mannosides in the interaction between mycobacteria and DC-SIGN. Infect Immun (2009) 0.93
The Mycobacterium tuberculosis PE proteins Rv0285 and Rv1386 modulate innate immunity and mediate bacillary survival in macrophages. PLoS One (2012) 0.93
Role of interleukin-10 in the pathogenesis of necrotizing enterocolitis. Am J Surg (2012) 0.92
Human IL10 gene repression by Rev-erbα ameliorates Mycobacterium tuberculosis clearance. J Biol Chem (2013) 0.88
Improve protective efficacy of a TB DNA-HSP65 vaccine by BCG priming. Genet Vaccines Ther (2007) 0.88
Blocking the receptor for interleukin 10 protects mice from lethal listeriosis. Antimicrob Agents Chemother (2001) 0.88
In pulmonary paracoccidioidomycosis IL-10 deficiency leads to increased immunity and regressive infection without enhancing tissue pathology. PLoS Negl Trop Dis (2013) 0.87
Interleukin-6: a potent biomarker of mycobacterial infection. Springerplus (2013) 0.87
Interleukin-10 and interferon-gamma patterns during tuberculosis treatment: possible association with recurrence. Int J Tuberc Lung Dis (2012) 0.86
Mycobacteria bypass mucosal NF-kB signalling to induce an epithelial anti-inflammatory IL-22 and IL-10 response. PLoS One (2014) 0.85
Role of PPE18 protein in intracellular survival and pathogenicity of Mycobacterium tuberculosis in mice. PLoS One (2012) 0.85
Natural transmission of Plasmodium berghei exacerbates chronic tuberculosis in an experimental co-infection model. PLoS One (2012) 0.85
CD36 deficiency attenuates experimental mycobacterial infection. BMC Infect Dis (2010) 0.85
CD4+ CD25+ transforming growth factor-beta-producing T cells are present in the lung in murine tuberculosis and may regulate the host inflammatory response. Clin Exp Immunol (2007) 0.83
Experimental Pseudomonas aeruginosa keratitis in interleukin-10 gene knockout mice. Infect Immun (2003) 0.83
IL-10 and NOS2 modulate antigen-specific reactivity and nerve infiltration by T cells in experimental leprosy. PLoS Negl Trop Dis (2014) 0.80
Association of interleukin-10 cytokine expression status with HLA non-DRB1*02 and Mycobacterium bovis BCG scar-negative status in south Indian pulmonary tuberculosis patients. Infect Immun (2001) 0.79
A deficiency in gamma interferon or interleukin-10 modulates T-Cell-dependent responses to heat shock protein 60 from Histoplasma capsulatum. Infect Immun (2005) 0.79
Biology of IL-27 and its role in the host immunity against Mycobacterium tuberculosis. Int J Biol Sci (2015) 0.77
Presence of RD149 deletions in M. tuberculosis Central Asian Strain 1 isolates affect growth and TNFα induction in THP-1 monocytes. PLoS One (2011) 0.76
Adaptation of Mycobacterium tuberculosis to Impaired Host Immunity in HIV-Infected Patients. J Infect Dis (2016) 0.75
The association of interleukin-10 -1082, -819, -592 polymorphisms and tuberculosis risk. Saudi Med J (2015) 0.75
Immune Responses to Bacillus Calmette-Guérin Vaccination: Why Do They Fail to Protect against Mycobacterium tuberculosis? Front Immunol (2017) 0.75
One Episode of Self-Resolving Plasmodium yoelii Infection Transiently Exacerbates Chronic Mycobacterium tuberculosis Infection. Front Microbiol (2016) 0.75
Mycobacterium tuberculosis PE_PGRS41 Enhances the Intracellular Survival of M. smegmatis within Macrophages Via Blocking Innate Immunity and Inhibition of Host Defense. Sci Rep (2017) 0.75
The role of IL-10 in Mycobacterium avium subsp. paratuberculosis infection. Cell Commun Signal (2016) 0.75
Interleukin-10-deficient mice develop chronic enterocolitis. Cell (1993) 22.57
An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med (1993) 18.56
Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med (1993) 17.01
Interleukin-10. Annu Rev Immunol (1993) 10.14
Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med (1992) 10.08
Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Invest (1996) 7.97
Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci U S A (1997) 7.90
Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med (1989) 7.72
A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med (1996) 7.66
Macrophage deactivation by interleukin 10. J Exp Med (1991) 6.94
Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. N Engl J Med (1996) 5.36
Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science (1994) 4.50
Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect Immun (1995) 4.28
Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J Exp Med (1996) 3.74
Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guérin and subsequent challenge with lipopolysaccharide. J Exp Med (1993) 3.48
Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10. J Biol Chem (1992) 3.18
Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta. J Exp Med (1993) 3.06
IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways. EMBO J (1998) 2.99
Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis. J Clin Invest (1997) 2.76
Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. J Clin Invest (1998) 2.67
IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J Immunol (1997) 2.50
Enhanced production of TGF-beta by blood monocytes from patients with active tuberculosis and presence of TGF-beta in tuberculous granulomatous lung lesions. J Immunol (1995) 2.21
The protective immune response to Mycobacterium tuberculosis. Curr Opin Immunol (1995) 2.21
Modulation of macrophage function by transforming growth factor beta, interleukin-4, and interleukin-10. Ann N Y Acad Sci (1993) 2.20
T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. J Immunol (1997) 2.18
A mammalian SRB protein associated with an RNA polymerase II holoenzyme. Nature (1996) 2.16
Infection with Mycobacterium avium induces production of interleukin-10 (IL-10), and administration of anti-IL-10 antibody is associated with enhanced resistance to infection in mice. Infect Immun (1993) 2.10
A receptor for interleukin 10 is related to interferon receptors. Proc Natl Acad Sci U S A (1993) 1.91
Three-dimensional structure of recombinant human interferon-gamma. Science (1991) 1.88
Both innate and acquired immunity to Listeria monocytogenes infection are increased in IL-10-deficient mice. J Immunol (1997) 1.87
IL-10 neutralization augments mouse resistance to systemic Mycobacterium avium infections. J Immunol (1993) 1.87
Growth inhibition of Mycobacterium bovis by IFN-gamma stimulated macrophages: regulation by endogenous tumor necrosis factor-alpha and by IL-10. Int Immunol (1994) 1.68
Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guérin strains that secrete cytokines. Proc Natl Acad Sci U S A (1996) 1.62
Crystal structure of interleukin-10 reveals the functional dimer with an unexpected topological similarity to interferon gamma. Structure (1995) 1.54
Mechanism of suppression of nitric oxide synthase expression by interleukin-4 in primary mouse macrophages. J Leukoc Biol (1994) 1.45
Role of interleukin-10 in regulation of T-cell-dependent and T-cell-independent mechanisms of resistance to Toxoplasma gondii. Infect Immun (1997) 1.44
Hematopoietic remodeling in interferon-gamma-deficient mice infected with mycobacteria. Blood (1998) 1.32
Interleukin 10 suppression of monocyte prostaglandin H synthase-2. Mechanism of inhibition of prostaglandin-dependent matrix metalloproteinase production. J Biol Chem (1994) 1.19
Spontaneously increased production of nitric oxide and aberrant expression of the inducible nitric oxide synthase in vivo in the transforming growth factor beta 1 null mouse. J Exp Med (1996) 1.19
Evidence against a role for interleukin-10 in the regulation of growth of Mycobacterium avium in human monocytes. J Infect Dis (1996) 1.08
Functional regions of the mouse interleukin-10 receptor cytoplasmic domain. Mol Cell Biol (1995) 1.07
IL-4, IL-5 and IL-10 are not required for the control of M. bovis-BCG infection in mice. Immunol Cell Biol (1998) 1.05
Regulation by interleukin-10 and interleukin-4 of cyclooxygenase-2 expression in human neutrophils. Blood (1997) 1.01
Opposing effects of interferon-gamma on iNOS and interleukin-10 expression in lipopolysaccharide- and mycobacterial lipoarabinomannan-stimulated macrophages. Immunology (1995) 1.01
The crucial role of IL-10 in the suppression of the immunological response in mice exposed to staphylococcal enterotoxin B. Eur J Immunol (1998) 1.00
Role of IL-12 in the initiation of cell mediated immunity by Toxoplasma gondii and its regulation by IL-10 and nitric oxide. J Eukaryot Microbiol (1995) 0.99
Efficient isolation of genes by using antibody probes. Proc Natl Acad Sci U S A (1983) 34.00
Genome-wide location and function of DNA binding proteins. Science (2000) 31.25
Dissecting the regulatory circuitry of a eukaryotic genome. Cell (1998) 23.62
Yeast RNA polymerase II genes: isolation with antibody probes. Science (1983) 17.91
Remodeling of yeast genome expression in response to environmental changes. Mol Biol Cell (2001) 9.63
Serial regulation of transcriptional regulators in the yeast cell cycle. Cell (2001) 7.99
Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus. J Virol (1990) 7.90
Dissection of Mycobacterium tuberculosis antigens using recombinant DNA. Proc Natl Acad Sci U S A (1985) 7.46
Genes for the major protein antigens of the leprosy parasite Mycobacterium leprae. Nature (1985) 6.54
Epitope tagging and protein surveillance. Methods Enzymol (1991) 6.47
An RNA polymerase II holoenzyme responsive to activators. Nature (1994) 6.22
Transcription of eukaryotic protein-coding genes. Annu Rev Genet (2000) 6.12
Genome-wide distribution of ORC and MCM proteins in S. cerevisiae: high-resolution mapping of replication origins. Science (2001) 6.06
Stress proteins are immune targets in leprosy and tuberculosis. Proc Natl Acad Sci U S A (1988) 5.68
The plasticity of dendritic cell responses to pathogens and their components. Science (2001) 5.58
Efficient mapping of protein antigenic determinants. Proc Natl Acad Sci U S A (1986) 5.38
A multisubunit complex associated with the RNA polymerase II CTD and TATA-binding protein in yeast. Cell (1993) 5.35
Tissue-specific expression of mouse-alpha-amylase genes: nucleotide sequence of isoenzyme mRNAs from pancreas and salivary gland. Cell (1980) 5.25
A single mouse alpha-amylase gene specifies two different tissue-specific mRNAs. Cell (1981) 5.03
A kinase-cyclin pair in the RNA polymerase II holoenzyme. Nature (1995) 4.93
Negative regulation of Gcn4 and Msn2 transcription factors by Srb10 cyclin-dependent kinase. Genes Dev (2001) 4.91
Complementary sequences 1700 nucleotides apart form a ribonuclease III cleavage site in Escherichia coli ribosomal precursor RNA. Proc Natl Acad Sci U S A (1978) 4.90
Chromosomal landscape of nucleosome-dependent gene expression and silencing in yeast. Nature (1999) 4.71
The ribonuclease III site flanking 23S sequences in the 30S ribosomal precursor RNA of E. coli. Cell (1980) 4.19
Sequence of the 16 S-23 s spacer region in two ribosomal RNA operons of Escherichia coli. J Biol Chem (1979) 4.19
Functional redundancy and structural polymorphism in the large subunit of RNA polymerase II. Cell (1987) 4.15
Temporal regulation of RNA polymerase II by Srb10 and Kin28 cyclin-dependent kinases. Mol Cell (1998) 4.09
RNA polymerase II holoenzyme contains SWI/SNF regulators involved in chromatin remodeling. Cell (1996) 4.03
Using graphical models and genomic expression data to statistically validate models of genetic regulatory networks. Pac Symp Biocomput (2001) 3.97
Prokaryotic and eukaryotic RNA polymerases have homologous core subunits. Proc Natl Acad Sci U S A (1987) 3.80
Oxpentifylline treatment of venous ulcers of the leg. BMJ (1990) 3.75
Human T-cell clones recognize a major M. leprae protein antigen expressed in E. coli. Nature (1986) 3.51
Tandem promoters direct E. coli ribosomal RNA synthesis. Cell (1979) 3.36
RNA polymerase II subunit RPB4 is essential for high- and low-temperature yeast cell growth. Mol Cell Biol (1989) 3.21
Redundant roles for the TFIID and SAGA complexes in global transcription. Nature (2000) 3.21
Lambda gt 11: gene isolation with antibody probes and other applications. Methods Enzymol (1987) 3.17
Intragenic and extragenic suppressors of mutations in the heptapeptide repeat domain of Saccharomyces cerevisiae RNA polymerase II. Genetics (1989) 3.04
Multiple polyadenylation sites in a mouse alpha-amylase gene. Nucleic Acids Res (1981) 2.96
The RNA polymerase II holoenzyme and its implications for gene regulation. Trends Biochem Sci (1995) 2.96
Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene. Cancer Res (2000) 2.91
General requirement for RNA polymerase II holoenzymes in vivo. Proc Natl Acad Sci U S A (1995) 2.88
The Fibres of Retiform Tissue. J Physiol (1892) 2.87
Association of Cdk-activating kinase subunits with transcription factor TFIIH. Nature (1995) 2.87
Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines. Nature (1991) 2.83
Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1. J Exp Med (1994) 2.81
Genes for the major protein antigens of Mycobacterium tuberculosis: the etiologic agents of tuberculosis and leprosy share an immunodominant antigen. Proc Natl Acad Sci U S A (1987) 2.79
Two dissociable subunits of yeast RNA polymerase II stimulate the initiation of transcription at a promoter in vitro. J Biol Chem (1991) 2.76
Mouse liver and salivary gland alpha-amylase mRNAs differ only in 5' non-translated sequences. Nature (1981) 2.73
The etiologic agents of leprosy and tuberculosis share an immunoreactive protein antigen with the vaccine strain Mycobacterium bovis BCG. Infect Immun (1987) 2.66
Gene replacement and expression of foreign DNA in mycobacteria. J Bacteriol (1990) 2.65
Association of an activator with an RNA polymerase II holoenzyme. Genes Dev (1995) 2.61
BRCA1 is a component of the RNA polymerase II holoenzyme. Proc Natl Acad Sci U S A (1997) 2.55
Transposition of the Escherichia coli insertion element gamma generates a five-base-pair repeat. Proc Natl Acad Sci U S A (1979) 2.47
RNA polymerase II C-terminal repeat influences response to transcriptional enhancer signals. Nature (1990) 2.46
RNA polymerase II holoenzymes and subcomplexes. J Biol Chem (1998) 2.39
An activator target in the RNA polymerase II holoenzyme. Mol Cell (1998) 2.37
The ankle injury--indications for the selective use of X-rays. Injury (1983) 2.35
Characterization of antibody-reactive epitopes on the 65-kilodalton protein of Mycobacterium leprae. Infect Immun (1987) 2.30
Stress proteins may provide a link between the immune response to infection and autoimmunity. Int Immunol (1989) 2.21
Gene isolation by screening lambda gt11 libraries with antibodies. Methods Enzymol (1987) 2.20
Human T cell clones recognize two abundant Mycobacterium tuberculosis protein antigens expressed in Escherichia coli. J Immunol (1987) 2.19
T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. J Immunol (1997) 2.18
A mammalian SRB protein associated with an RNA polymerase II holoenzyme. Nature (1996) 2.16
An unusual eukaryotic protein phosphatase required for transcription by RNA polymerase II and CTD dephosphorylation in S. cerevisiae. Mol Cell (1999) 2.14
Regulation of gene expression by TBP-associated proteins. Genes Dev (1998) 2.12
Mapping of T cell epitopes using recombinant antigens and synthetic peptides. EMBO J (1987) 2.09
Subunits shared by eukaryotic nuclear RNA polymerases. Genes Dev (1990) 2.09
A novel transcription factor reveals a functional link between the RNA polymerase II CTD and TFIID. Cell (1992) 1.98
The yeast A kinases differentially regulate iron uptake and respiratory function. Proc Natl Acad Sci U S A (2000) 1.98
The mouse alpha-amylase multigene family. Sequence organization of members expressed in the pancreas, salivary gland and liver. J Mol Biol (1982) 1.96
T lymphocytes from healthy individuals with specificity to self-epitopes shared by the mycobacterial and human 65-kilodalton heat shock protein. J Immunol (1989) 1.94
Conditional mutations occur predominantly in highly conserved residues of RNA polymerase II subunits. Mol Cell Biol (1990) 1.92
RNA polymerase II subunit composition, stoichiometry, and phosphorylation. Mol Cell Biol (1990) 1.85
A portion of RNA polymerase II molecules has a component essential for stress responses and stress survival. Mol Cell Biol (1993) 1.83
RNA polymerase II subunit RPB3 is an essential component of the mRNA transcription apparatus. Mol Cell Biol (1989) 1.81
The uraA locus and homologous recombination in Mycobacterium bovis BCG. J Bacteriol (1993) 1.75
Screening of a recombinant mycobacterial DNA library with polyclonal antiserum and molecular weight analysis of expressed antigens. Infect Immun (1987) 1.74
RPB7, one of two dissociable subunits of yeast RNA polymerase II, is essential for cell viability. Yeast (1993) 1.71
Transcription termination in the Escherichia coli ribosomal RNA operon rrnC. J Biol Chem (1979) 1.70
Interplay of positive and negative regulators in transcription initiation by RNA polymerase II holoenzyme. Mol Cell Biol (1998) 1.69
Yeast RNA polymerase II subunit RPB9 is essential for growth at temperature extremes. J Biol Chem (1991) 1.67
A chemoattractant cytokine associated with granulomas in tuberculosis and silicosis. Proc Natl Acad Sci U S A (1997) 1.67
Attenuated host resistance against Mycobacterium bovis BCG infection in mice lacking osteopontin. Infect Immun (1999) 1.65
In vivo and in vitro characterization of murine T-cell clones reactive to Mycobacterium tuberculosis. Infect Immun (1987) 1.63
RNA polymerase II carboxy-terminal domain contributes to the response to multiple acidic activators in vitro. Genes Dev (1991) 1.63
Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guérin strains that secrete cytokines. Proc Natl Acad Sci U S A (1996) 1.62
Isolation of HTLV-transformed B-lymphocyte clone from a patient with HTLV-associated adult T-cell leukaemia. Nature (1984) 1.58
Identification of the gal4 suppressor Sug1 as a subunit of the yeast 26S proteasome. Nature (1996) 1.47
The safety of overnight hospitalization for transurethral prostatectomy: a prospective study of 200 patients. J Urol (1997) 1.46
Heat shock fusion proteins as vehicles for antigen delivery into the major histocompatibility complex class I presentation pathway. Proc Natl Acad Sci U S A (1997) 1.46
Yeast NC2 associates with the RNA polymerase II preinitiation complex and selectively affects transcription in vivo. Mol Cell Biol (2001) 1.45
Mutations in the three largest subunits of yeast RNA polymerase II that affect enzyme assembly. Mol Cell Biol (1991) 1.44
RNA polymerase II mutants defective in transcription of a subset of genes. Mol Cell Biol (1990) 1.42
A protein antigen of Mycobacterium leprae is related to a family of small heat shock proteins. J Bacteriol (1988) 1.41
Recombinant Mycobacterium bovis BCG secreting functional interleukin-2 enhances gamma interferon production by splenocytes. Infect Immun (1994) 1.39
Mutations in a conserved region of RNA polymerase II influence the accuracy of mRNA start site selection. Mol Cell Biol (1991) 1.39
Tumor necrosis factor alpha is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system. Proc Natl Acad Sci U S A (1999) 1.38
Adjuvant-free hsp70 fusion protein system elicits humoral and cellular immune responses to HIV-1 p24. J Immunol (1996) 1.38
Vaccinia virus infection induces a stress response that leads to association of Hsp70 with viral proteins. J Virol (1992) 1.36
CA150, a nuclear protein associated with the RNA polymerase II holoenzyme, is involved in Tat-activated human immunodeficiency virus type 1 transcription. Mol Cell Biol (1997) 1.36